Posts by tag
oncodaily
Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist
It was 2018, and I was a fifth-year medical student at Yerevan State Medical University. Word spread that our new oncology professor was someone extraordinary: Gevorg Tamamyan - a Harvard-trained, Nature-published pioneer of pediatric oncology in Armenia and president of…
How a Chicken Egg Model Could Transform Pediatric Cancer Treatment in Canada
A new, innovative pipeline fusing genomics, proteomics and modelling in animals and chicken eggs is pinpointing new treatments for children with rare and relapsed cancers in Canada. Researchers in Canada have used fertilized chicken eggs to grow tumors from children…
Microbiota-Derived Bile Acids as Androgen Receptor Antagonists Enhance Anti-Tumour Immunity
The gut microbiota can transform cholesterol-derived bile acids into metabolites capable of blocking androgen receptors and strengthening anti-cancer immunity. The study, published in Cell, April 15, demonstrates how one of the microbiota-derived secondary bile acids is capable of suppressing tumour…
Adrian Gottschalk: Making a Difference for His Fellow Human Beings
I grew up around a lot of physicians,” begins Adrian Gottschalk, President and CEO of Foghorn Therapeutics, a biotech company redefining how we understand and treat complex diseases by targeting the chromatin regulatory system. “My late father was a professor…
Matti Aapro: An Oncologist Who Needs No Introduction
If you have ever stepped into a major oncology congress, you’ve likely felt his presence before you saw him. His voice, distinct and commanding, cuts through a room not with volume, but with purpose. His laugh, genuine and disarming, puts…